Skip to content
No results
  • Home
  • About Us
  • Products
    • Battery Material
      • Battery Additives
      • Ether Fluoride Cosolvent
      • Silicon Carbon Anode
    • Display Materials
      • Mixed Liquid Crystal
      • Monomer Liquid Crystal
      • OLED Materials
      • Liquid Crystal Intermediate
      • Polyimide (PI) material
    • Biological Reagent
      • Primary Antibodies
      • Secondary Antibodies
    • Pharmaceutical Intermediates
    • Other Chemicals
  • News
    • Company news
    • Industry news
  • Contact Us
T-Rock
  • Home
  • About Us
  • Products
    • Battery Material
      • Battery Additives
      • Ether Fluoride Cosolvent
      • Silicon Carbon Anode
    • Display Materials
      • Mixed Liquid Crystal
      • Monomer Liquid Crystal
      • OLED Materials
      • Liquid Crystal Intermediate
      • Polyimide (PI) material
    • Biological Reagent
      • Primary Antibodies
      • Secondary Antibodies
    • Pharmaceutical Intermediates
    • Other Chemicals
  • News
    • Company news
    • Industry news
  • Contact Us
Contact Us
T-Rock
Home Display Materials OLED Materials 2,4-dichloro-benzo[4,5]thieno[3,2-d]pyrimidine

2,4-dichloro-benzo[4,5]thieno[3,2-d]pyrimidine

CAS: 160199-05-3

Category: OLED Materials

Related products

  • 8-Bromo-11H-Benzo[A]Carbazole

    CAS: 21064-34-6

    • OLED Materials

  • 5-BROMO-7H-BENZO[C]CARBAZOLE

    CAS: 131409-18-2

    • OLED Materials

  • 7H-12-Thia-7-aza-indeno[1,2-a]fluorene

    CAS: 1255308-97-4

    • OLED Materials

  • B-(6,9-Diphenyl-9H-carbazol-3-yl)boronic acid

    CAS: 1133058-06-6

    • OLED Materials

Technological innovation for the benefit of mankind. --- Changsha T-rock Biochem Co., Ltd

Quick Links

  • Home
  • About Us
  • Contact Us
  • Products
    • Primary Antibodies
  • Blog
Contact Us

Need help or have a question?

Email: INFO@T-ROCKCHEM.COM
ADD: XIDI BUILDING, NO.8 FENGLIN SAN ROAD, YUELU DISTRICT, CHANGSHA CITY, HUNAN PROVINCE,CHINA

Copyright © 2025 - T-Rock 

If you need anything, please contact us.

Please enable JavaScript in your browser to complete this form.
Loading